OPC-12759
Showing 1 - 25 of 156
Dry Eye Syndromes Trial in Osaka (OPC-12759 Ophthalmic solution, OPC-12759 Ophthalmic suspension)
Completed
- Dry Eye Syndromes
- OPC-12759 Ophthalmic solution
- OPC-12759 Ophthalmic suspension
-
Osaka, JapanKansai region
Jun 3, 2021
Trajectories of Fatigue and Quality of Life in People With Both
Not yet recruiting
- Pancreatic Cancer Resectable
- Diabetes Mellitus
- (no location specified)
Aug 22, 2023
Multidimensional and Multimodal Profiling of Oropharyngeal
Not yet recruiting
- Oropharyngeal Carcinoma
- Human Papilloma Virus
-
Palo Alto, CaliforniaStanford University
May 25, 2023
Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and
Not yet recruiting
- Pulmonary Tuberculosis
- Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
- +3 more
- (no location specified)
Jul 25, 2023
Oropharyngeal Cancer Trial in Shanghai (Toxicities reduced treatment, Conventional treatment)
Recruiting
- Oropharyngeal Cancer
- Toxicities reduced treatment
- Conventional treatment
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Nov 26, 2023
MDD Trial in Tokyo (OPC-64005 20 mg , Once-daily, OPC-64005 10 mg , Once-daily, Placebo, Once-daily)
Completed
- Major Depressive Disorder
- OPC-64005 20 mg , Once-daily
- +2 more
-
Tokyo, JapanMedical Corporation Jisenkai Himorogi Psychiatric Institute
Sep 7, 2022
Oral Cancer, Pharynx Cancer, Sleep Apnea Trial (Ronco-Onco and MAD)
Not yet recruiting
- Oral Cancer
- +4 more
- Ronco-Onco and MAD
- (no location specified)
Jan 30, 2023
Open Angle Glaucoma or Ocular Hypertension Trial in Shanghai (OPC-1085EL, 0.005% Latanoprost)
Recruiting
- Open Angle Glaucoma or Ocular Hypertension
- OPC-1085EL
- 0.005% Latanoprost
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Oct 14, 2022
The PIPAC PET Pilot Study, OPC-7
Not yet recruiting
- Peritoneal Cancer
- +3 more
- scan
- (no location specified)
Nov 17, 2023
Oropharyngeal Candidiasis (OPC) and S-ECC
Recruiting
- Candida Infection
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Mar 10, 2023
Healthy Adult Male Trial in Beijing (OPC-61815 injection)
Recruiting
- Healthy Adult Male
- OPC-61815 injection
-
Beijing, ChinaClinical Pharmacology Research Center, Peking Union Medical Coll
Jul 4, 2022
ADHD Trial in United States (OPDC-34712 + Stimulant Therapy, Placebo + Stimulant Therapy)
Completed
- Attention Deficit Hyperactivity Disorder
- OPDC-34712
- +2 more
-
Little Rock, Arkansas
- +34 more
Jan 6, 2023
Breast Cancer Trial in Charleston (OPC)
Terminated
- Breast Cancer
-
Charleston, South CarolinaMedical University of South Carolina
Aug 9, 2022
Healthy Adult Male Trial in Leeds ((14C)-OPC-61815)
Completed
- Healthy Adult Male
-
Leeds, United KingdomCovance Clinical Research Unit Ltd
Sep 8, 2021
Cardiac Edema (CHF) Trial in Fukuoka (OPC 131461 10mg group, OPC 131461 5mg group, OPC 131461 2mg group)
Recruiting
- Cardiac Edema (CHF)
- OPC 131461 10mg group
- +4 more
-
Fukuoka, JapanHarasanshin Hospital
Nov 7, 2022
Developmental Disability Trial in Kowloon, Kwun Tong, North Point (Occupational Performance coaching, Parent consultation)
Recruiting
- Developmental Disability
- Occupational Performance coaching
- Parent consultation
-
Kowloon, Hong Kong
- +2 more
Mar 17, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Blood test for HPV DNA
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug Resistant, Extensively Drug-Resistant Tuberculosis Trial in Worldwide
Using Human Papillomavirus DNA Testing to Detect HPV-Related
Recruiting
- Oropharyngeal Cancer
- +2 more
- NavDx
-
Basking Ridge, New Jersey
- +6 more
Apr 3, 2023
Epilepsy Trial in Ormond Beach (OPC-214870, Placebo)
Completed
- Epilepsy
- OPC-214870
- Placebo
-
Ormond Beach, FloridaFor additional information regarding sites, contact 844-687-8522
Aug 19, 2022
Pulmonary TB Trial in South Africa (Delamanid + Bedaquiline + OPC-167832 10 mg, Delamanid + Bedaquiline + OPC-167832 30 mg,
Recruiting
- Pulmonary TB
- Delamanid + Bedaquiline + OPC-167832 10 mg
- +3 more
-
Tembisa, Gauteng, South Africa
- +7 more
Jun 30, 2022
Multiple Sclerosis, Quality of Life Trial in Kingston (Occupational Performance Coaching)
Active, not recruiting
- Multiple Sclerosis
- Quality of Life
- Occupational Performance Coaching
-
Kingston, Ontario, CanadaQueen's University
Apr 27, 2022
Multiple Myeloma (MM) Trial in Japan (OPC-415)
Recruiting
- Multiple Myeloma (MM)
- OPC-415
-
Isehara-shi, Japan
- +4 more
Apr 20, 2022
Organ Donation, Required Organ Donation Request, Professional Family Relations Trial in Nantes (Collaborative request)
Recruiting
- Organ Donation
- +3 more
- Collaborative request
-
Nantes, Pays De La Loire, FranceCHU Nantes
Dec 21, 2022